Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents

The administration of a third dose of a vaccine against SARS-CoV-2 has increased protection against disease transmission and severity. However, the kinetics of neutralizing antibodies against the virus has been poorly studied in cancer patients under targeted therapies. Baseline characteristics and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zagouri, Flora, Papatheodoridi, Alkistis, Liontos, Michalis, Briasoulis, Alexandros, Sklirou, Aimilia D., Skafida, Efthymia, Fiste, Oraianthi, Markellos, Christos, Andrikopoulou, Angeliki, Koutsoukos, Konstantinos, Kaparelou, Maria, Gkogkou, Eirini, Trougakos, Ioannis P., Dimopoulos, Meletios-Athanasios, Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505348/
https://www.ncbi.nlm.nih.gov/pubmed/36146552
http://dx.doi.org/10.3390/vaccines10091474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505348/
https://www.ncbi.nlm.nih.gov/pubmed/36146552
http://dx.doi.org/10.3390/vaccines10091474

Ejemplares similares